Listening to #sanofi scientist explain that #iniparib isn't really a #PARP inihibitor. They should've called it notaparib. #Phacilitate
#BiPar Ph 3 results are an important reminder that even strong Ph1/Ph2 signals don't insure against Ph3 failure. #BSI-201 #iniparib #cancer
